Home> Products> robust control

{ "products": [ { "_id": "6948f4ee5837f90c86a7e578", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Elagolix Tablets 200mg ", "description": "Eligolux200 contains 200 mg of elagolix per tablet and is manufactured by Steris Healthcare Pvt Ltd in India as a prescription medication in packs of 3x10 tablets. Elagolix acts as a potent gonadotropin-releasing hormone (GnRH) receptor antagonist, binding competitively to GnRH receptors in the pituitary gland to rapidly reduce estrogen and progesterone levels without the initial flare-\nup seen in agonists. This mechanism starves endometrial-like tissue outside the uterus of hormonal stimulation, shrinking lesions and easing inflammation.\n​\n\nAdminister Eligolux200 orally, swallowed whole with water, with or without food, typically starting within 7 days of menstrual onset. Standard dosing for severe cases involves 200mg twice daily for up to 6 months, or 150mg once daily extended to 24 months, adjusted by physicians based on tolerance and response. Store in a cool, dry place away from moisture and light, keeping out of children's reach.\n​\n\nPrimary Uses\nEligolux200 targets moderate to severe endometriosis-associated pain, including dysmenorrhea (painful periods), nonmenstrual pelvic pain, and dyspareunia (painful intercourse). Endometriosis affects millions globally, causing tissue similar to the uterine lining to grow ectopically, leading to chronic inflammation, adhesions, and scarring. By dosing flexibly, Eligolux200 suits patients needing stronger suppression for intense symptoms, reducing reliance on opioids or surgery.\n​\n\nClinical trials like Elaris EM-I and EM-II showed 75% dysmenorrhea reduction and 50-60% nonmenstrual pain relief at 6-12 months. It also curbs heavy menstrual bleeding in uterine fibroids, offering dual benefits for overlapping conditions. Physicians prescribe it when first-line NSAIDs or oral contraceptives fail, prioritizing non-invasive symptom control.\n​\n\nKey Benefits\nEligolix in Eligolux200 delivers rapid pain relief, with significant improvements in daily pain scales within 3 months versus placebo. Women report 47% better composite pelvic pain scores, enhancing daily activities, work productivity, and intimacy. Quality-of-life metrics improve consistently over 24 weeks, including reduced fatigue and better emotional well-being.\n​\n\nUnlike injectables, its oral form and dose-dependent estrogen suppression allow titration—lower doses minimize hypoestrogenic effects while higher 200mg dosing tackles severe pain. Studies confirm amenorrhea in 25% of users early on, slashing bleeding days by up to 50%. Long-term data up to 12 months with add-back therapy sustains efficacy, preserving bone health better than monotherapy. Patients regain control, avoiding invasive laparoscopies and reclaiming normalcy.\n​\n\nBenefit\tEvidence from Trials'\tImpact on Patients\nDysmenorrhea Reduction:\t75% at 6 months \n​\tFewer missed workdays\nNonmenstrual Pain Relief:\t50-60% improvement \n​\tEnhanced mobility\nBleeding Control:\t14% bleeding days vs. 24% baseline \n​\tImproved hygiene, anemia prevention\nQuality of Life\tSustained over 24 weeks \n​\tBetter sleep, relationships\nPotential Side Effects\nCommon side effects of Eligolux200 mirror hypoestrogenic states: hot flashes, night sweats, headache, and nausea, each affecting about 10% of users. These often lessen as the body adjusts, with 69.5% overall adverse event rate over 24 weeks, mostly mild. Mood changes like irritability or depression occur less commonly, warranting mood monitoring.\n​\n\nBone mineral density (BMD) loss poses a key concern—200mg twice daily causes -1.5% to -2.4% drops at lumbar spine and hip after 6 months, attenuated with calcium/vitamin D or add-back therapy. Rare serious risks include suicidal thoughts, liver enzyme elevations, or allergic reactions like anaphylaxis. Discontinuation due to events stays low at 4-12%. No deaths are linked directly to treatment in trials.\n​\n\nSide Effect Category\tFrequency\tManagement\nVasomotor (Hot Flashes)\t9.9-10% \n​\tLifestyle cooling, dose adjustment\nNeurologic (Headache)\t9.9% \n​\tHydration, analgesics\nBone Loss\tUp to 2.4% at 6 months \n​\tDEXA scans, supplements\nMood Changes\tLess common \n​\tPsychiatric screening\nPrecautions and Contraindications\nAvoid Eligolux200 in pregnancy (risk of early loss), known osteoporosis, severe hepatic impairment, or with strong OATP1B1 inhibitors like cyclosporine or gemfibrozil. Women of childbearing age need effective non-hormonal contraception during and 28 days post-therapy, as it impairs recognition of pregnancy via amenorrhea. Not for pediatrics under 18 or geriatrics lacking data.\n​\n\nScreen for depression history, liver function, and BMD before starting; monitor quarterly. Drug interactions abound with rifampin (reduces levels) or over 50 others like clarithromycin—inform physicians fully. Breastfeeding lacks safety data; weigh risks. Regular blood/urine tests track efficacy and safety.\n​\n\nDosage Guidelines\nInitiate Eligolux200 at 150mg daily for milder cases, escalating to 200mg BID for dyspareunia or severe pain, max 6 months at higher dose. Miss a dose? Take promptly unless near next; never double. Duration caps at 24 months total, with liver-adjusted lower dosing. Pair with add-back for extended use to curb BMD loss.\n​\n\nPhysicians tailor based on response: 74-77% complete 6-month trials. Swallow intact; no crushing.\n​\n\nClinical Evidence\nPhase III trials (Elaris EM-I/II) randomized 1689 women, proving both doses superior to placebo for co-primary endpoints of dysmenorrhea and nonmenstrual pain. Open-label extensions to 24 weeks maintained gains. A 12-month study with add-back showed persistent relief and <1% additional BMD loss versus placebo. Real-world use echoes this, positioning Eligolix as first oral GnRH antagonist approved for endometriosis.\n​\n\nVersus relugolix, Eligolix offers comparable pelvic pain reduction with adjustable dosing. Indian brands like Eligolux200 align with global standards.\n​\n\nConclusion\nEligolux200 transforms endometriosis management, delivering substantial pain relief and functional gains through precise hormonal control. Balancing robust benefits against manageable risks like BMD monitoring empowers women toward symptom-free lives. Consult healthcare providers for personalized integration into care plans.\n", "price": 1.0, "discountamount": 0.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2251, "imageuri": "https://productimages.withfloats.com/actual/6948f4f0fe408c85572e7619.png", "tileimageuri": "https://productimages.withfloats.com/tile/6948f4f0fe408c85572e7619.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-22T07:36:14.316Z", "updatedon": "2025-12-22T10:26:35.194Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/elagolix-tablets-200mg-/2251", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ELIGOLUX 200", "category": "Gynaecology", "tags": [ "Elagolix Tablets 200mg", "Elagolix acts as a potent gonadotropin-releasing hormone.", "nonmenstrual pelvic pain.", "adhesions, and scarring", "preserving bone health better than monotherapy.", "avoiding invasive laparoscopies and reclaiming normalcy.", "pituitary gland to rapidly reduce estrogen and progesterone." ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6948e738796e72bd2659934b", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Micronized Purified Flavonoid Fraction MPFF Tablets 450mg Diosmin+50mg Hesperidin", "description": "Product Name: FLAVOSHIELD 500\nActive Ingredients: Micronized Purified Flavonoid Fraction (MPFF) 500mg, containing Diosmin 450mg and Hesperidin 50mg.\nPresentation: Oral Tablets\n\nUnveiling FLAVOSHIELD 500: A Deep Dive into Advanced Venous and Vascular Wellness\nIn the intricate network of the human circulatory system, veins perform the silent, relentless task of returning blood to the heart against gravity. When this system faces strain, it can manifest through discomfort, heaviness, and visible changes that impact both physical well-being and quality of life. Enter FLAVOSHIELD 500, a sophisticated pharmaceutical-grade formulation designed to fortify venous health at its core. Powered by a Micronized Purified Flavonoid Fraction (MPFF)—a precise blend of 450mg Diosmin and 50mg Hesperidin—FLAVOSHIELD 500 represents a pinnacle in venoactive therapy. This comprehensive description explores the product, its mechanism, multifaceted uses, key benefits, safety profile, and its role in a holistic health strategy.\n\nWhat is FLAVOSHIELD 500? The Science of MPFF\nFLAVOSHIELD 500 is not a simple herbal supplement; it is a clinically researched, standardized medical treatment. Its active core, the Micronized Purified Flavonoid Fraction, is derived from citrus fruits but undergoes a specialized purification and micronization process. This technological advancement is crucial:\n\nPurification: Ensures a consistent, high-potency concentration of the active flavonoid molecules, Diosmin and Hesperidin, free from plant impurities.\nMicronization: Reduces the particle size of the flavonoids dramatically, increasing their surface area. This leads to significantly enhanced absorption in the gastrointestinal tract, ensuring that a much higher percentage of the active dose reaches the bloodstream and, ultimately, the target venous tissues. Compared to non-micronized diosmin, MPFF offers up to 30% greater bioavailability, making FLAVOSHIELD 500 a more effective and reliable choice.\nThis synergy of Diosmin and Hesperidin works on multiple physiological pathways to restore venous tone and capillary integrity.\n\nPrimary Uses and Therapeutic Applications\nFLAVOSHIELD 500 is indicated for the management of various stages of chronic venous disorders and related conditions:\n\nChronic Venous Disease (CVD) & Venous Insufficiency: This is the primary use. It alleviates the distressing symptoms stemming from weakened vein walls and faulty valves in the legs. These include:\n\nHeaviness and Fatigue: The pervasive feeling of weight and tiredness in the legs, especially after prolonged standing or sitting.\nPain and Aching: Dull, throbbing, or cramping pain that improves with elevation.\nSwelling (Edema): Reduction of ankle and lower leg swelling caused by fluid leakage from capillaries.\nNocturnal Cramps: Relief from painful muscle spasms that often occur at night.\nHemorrhoidal Disease (Acute and Chronic): MPFF is a cornerstone in hemorrhoid management. It treats acute hemorrhoidal attacks by reducing bleeding, pain, and discharge. For chronic cases, it helps prevent recurrences by decreasing capillary fragility and inflammation in the anal venous plexus.\n\nPost-Phlebitic Syndrome: Following deep vein thrombosis (DVT), patients often suffer from chronic leg swelling, pain, and skin changes. FLAVOSHIELD 500 can be part of the management plan to improve microcirculation and reduce symptoms.\n\nSupport Post-Sclerotherapy or Surgical Procedures: It is commonly used after vein stripping, laser ablation, or sclerotherapy to support healing, reduce postoperative swelling and bruising, and help consolidate results.\n\nKey Benefits and Mechanism of Action: The Multi-Target Approach\nThe efficacy of FLAVOSHIELD 500 stems from its multi-faceted pharmacological actions on the venous and lymphatic systems:\n\nVenotonic Action: It increases venous tone and elasticity by promoting the contraction of smooth muscle in the vein walls. This helps veins propel blood more efficiently upward, reducing pooling and pressure. Think of it as “tightening” slackened venous structures.\n\nCapillary-Protective & Anti-Inflammatory Effects: It strengthens capillary walls (reduces capillary permeability) and inhibits the release of inflammatory mediators (like prostaglandins and leukotrienes). This dual action minimizes the leakage of fluid, proteins, and inflammatory cells into surrounding tissues, thereby directly addressing edema (swelling) and inflammation. This is particularly vital in hemorrhoidal tissue.\n\nLymphatic Enhancement: FLAVOSHIELD 500 has been shown to increase lymphatic drainage by boosting the frequency and intensity of lymphatic contractions. This provides an additional route for removing excess interstitial fluid and proteins, further reducing swelling.\n\nAntioxidant Activity: The flavonoids scavenge harmful free radicals, protecting venous and capillary endothelial cells from oxidative stress, which is a contributing factor in chronic venous disease.\n\nImprovement of Microcirculation: By reducing blood viscosity and inhibiting red blood cell aggregation, it improves blood flow in the smallest vessels, enhancing oxygen delivery and waste removal at the tissue level.\n\nPatient-Centric Benefits:\n\nRapid Symptom Relief: Patients often report a noticeable decrease in leg heaviness and pain within the first few weeks of treatment.\nEnhanced Quality of Life: Restores the ability to stand, walk, and engage in daily activities with greater comfort and less discomfort.\nReduced Reliance on Pain Medication: By addressing the underlying inflammation and pain of venous issues and hemorrhoids, it can decrease the need for NSAIDs.\nComplement to Compression Therapy: Works synergistically with compression stockings, often allowing for better tolerance and compliance with compression wear.\nSide Effects and Safety Profile: What to Expect\nFLAVOSHIELD 500 is generally very well-tolerated, with a low incidence of side effects, which are typically mild and transient. This excellent safety profile is a result of its natural origin and high purification.\n\nCommon Side Effects (Rare and usually mild):\n\nGastrointestinal: Some individuals may experience mild, transient digestive disturbances such as nausea, stomach pain, diarrhea, or heartburn. Taking the tablet with a meal can often mitigate this.\nNeurological: Occasional reports of headache or dizziness.\nAllergic Reactions: Very rare cases of skin rash or itching have been reported.\nImportant Safety Considerations:\n\nPregnancy and Lactation: While no teratogenic effects have been demonstrated, as a precaution, use during pregnancy (especially the first trimester) and breastfeeding should only be under the direct supervision of a physician who has weighed the benefits against potential risks.\nDrug Interactions: No significant pharmacokinetic drug interactions have been formally reported. However, as with any medication, it is prudent to inform your doctor about all other medicines and supplements you are taking.\nContraindications: Hypersensitivity to any of the components (Diosmin, Hesperidin, or excipients in the tablet) is a contraindication.\nCrucial Note: FLAVOSHIELD 500 is a treatment for symptoms and a stabilizer of venous function, not a cure for underlying venous valve incompetence. It does not replace definitive interventional treatments (like ablation or surgery) for advanced varicose veins when they are medically indicated. It is essential to receive a proper diagnosis from a healthcare professional to rule out other causes of leg swelling or pain (e.g., cardiac, renal, or hepatic origin).\n\nConclusion: FLAVOSHIELD 500 – A Cornerstone of Comprehensive Venous Care\nIn conclusion, FLAVOSHIELD 500 stands as a robust, scientifically validated agent in the realm of vascular health. Its advanced MPFF technology, combining 450mg of micronized Diosmin with 50mg of Hesperidin, delivers enhanced bioavailability and a powerful, multi-target action that addresses the root causes of venous discomfort: poor tone, capillary fragility, inflammation, and impaired lymphatic drainage.\n\nWhether battling the daily fatigue of heavy legs, managing the acute distress of a hemorrhoidal flare-up, or supporting recovery after a venous procedure, FLAVOSHIELD 500 offers a reliable and well-tolerated therapeutic option. Its benefits in improving symptoms and quality of life are clear, backed by a strong body of clinical evidence.\n\nHowever, optimal venous health is a holistic endeavor. FLAVOSHIELD 500 should be viewed as the pharmacological cornerstone of a broader management plan. This plan should include:\n\nMedical Supervision: Regular consultation with a vascular specialist or phlebologist.\nLifestyle Modifications: Weight management, regular low-impact exercise (walking, swimming), and elevation of the legs.\nCompression Therapy: The use of medically prescribed compression stockings when recommended.\nDietary Awareness: A fiber-rich diet to prevent constipation and straining.\nBy integrating FLAVOSHIELD 500 into this comprehensive approach, individuals can take proactive control of their venous health, shielding their vitality and comfort from the burdens of venous insufficiency. Always consult your healthcare provider to determine if FLAVOSHIELD 500 is appropriate for your specific condition and to establish the correct dosage and treatment duration.\n\nDisclaimer: This content is for informational purposes only and does not constitute medical advice. Always seek the guidance of a qualified healthcare professional with any questions regarding a medical condition or treatment. Do not delay seeking or disregard professional medical advice based on information contained here.", "price": 218.0, "discountamount": 66.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2250, "imageuri": "https://productimages.withfloats.com/actual/6948e7392f14bd83555d1409.png", "tileimageuri": "https://productimages.withfloats.com/tile/6948e7392f14bd83555d1409.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-22T06:37:44.038Z", "updatedon": "2025-12-22T10:26:13.147Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/micronized-purified-flavonoid-fraction-mpff-tablets-450mg-diosmin-50mg-hesperidin/2250", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "FLAVOSHIELD 500", "category": "GENERAL RANGE", "tags": [ "A Deep Dive into Advanced Venous and Vascular Wellness", "human circulatory system", "blood to the heart against gravity.", "Powered by a Micronized Purified Flavonoid Fraction (MPFF)", "Hemorrhoidal Disease", "By reducing blood viscosity and inhibiting red blood cell aggregation", "holistic health strategy.", "Chronic Venous Insufficiency (CVI)", "Varicose Veins", "Hemorrhoids (Piles)", "Venous Ulcers", "Lymphedema", "Post-Surgical Venous Recovery" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6943af86161ad9de85f42b10", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Imatinib IP 400mg", "description": "IMATIFLOW 400, containing Imatinib IP 400mg, represents a breakthrough in targeted cancer therapy, offering patients a precise weapon against specific malignancies. This oral medication belongs to the class of tyrosine kinase inhibitors, revolutionizing treatment for conditions once deemed challenging to manage. By blocking abnormal proteins that fuel cancer cell growth, IMATIFLOW 400 helps restore normal cellular function and improves quality of life for many users.​\n\nProduct Overview\nIMATIFLOW 400 is a branded formulation of Imatinib mesylate 400mg, produced to high pharmaceutical standards for consistent efficacy and bioavailability. Each tablet delivers the active ingredient in a film-coated form, designed for once-daily administration with food to enhance absorption and minimize gastrointestinal upset. Developed for adult patients, it targets cancers driven by dysregulated tyrosine kinases like BCR-ABL, c-KIT, and PDGFR, making it a cornerstone in modern oncology protocols.​\n\nThe medication's mechanism hinges on competitive inhibition at the ATP-binding site of these kinases, halting downstream signaling pathways that promote uncontrolled proliferation, survival, and metastasis of malignant cells. Unlike traditional chemotherapy, which broadly attacks dividing cells, IMATIFLOW 400 spares most healthy tissues, leading to a more favorable safety profile. Clinical data from pivotal trials underscore its role as first-line therapy, with high response rates observed within months of initiation.​\n\nPrimary Uses\nIMATIFLOW 400 excels in treating chronic myeloid leukemia (CML), particularly in the chronic phase where it induces deep molecular responses in over 80% of patients. It suppresses the Philadelphia chromosome-positive cells hallmark of CML by inhibiting the BCR-ABL fusion protein, dramatically extending progression-free survival. For newly diagnosed patients, standard dosing starts at 400mg daily, often achieving complete cytogenetic remission.​\n\nIn gastrointestinal stromal tumors (GIST), IMATIFLOW 400 targets KIT or PDGFRA mutations, shrinking unresectable tumors and delaying progression in advanced cases. The recommended dose remains 400mg once daily, with potential escalation to 600-800mg for resistant strains, as per oncology guidelines. It also finds application in dermatofibrosarcoma protuberans (DFSP), aggressive systemic mastocytosis, and certain myelodysplastic syndromes, broadening its utility in precision medicine.​\n\nHealthcare providers monitor response via PCR for BCR-ABL transcripts in CML or imaging for GIST, adjusting therapy based on milestones like major molecular response. Patients with Ph+ acute lymphoblastic leukemia (ALL) may receive it adjunctively, enhancing outcomes when combined with chemotherapy. Overall, IMATIFLOW 400 transforms these diseases from fatal to chronically manageable.​\n\nKey Benefits\nOne standout benefit of IMATIFLOW 400 is its oral convenience, eliminating the need for frequent hospital visits associated with infusions. Response rates exceed 90% in early CML, with many patients achieving treatment-free remission after sustained deep responses, a paradigm shift from interferon-era therapies.​\n\nTumor control in GIST prevents life-threatening complications like bowel obstruction, improving survival from months to years. Its specificity reduces severe toxicities, allowing patients to maintain daily activities, work, and social engagements with minimal disruption. Long-term studies report 10-year survival rates above 80% in CML, underscoring durable efficacy.​\n\nAdditional advantages include cost-effectiveness over biologics and compatibility with supportive care like hydroxyurea for cytoreduction. Fluid retention, while common, responds well to diuretics, preserving cardiac function. For Indian patients, accessible pricing via brands like IMATIFLOW 400 supports equitable care in resource-limited settings.​\n\nPotential Side Effects\nWhile generally well-tolerated, IMATIFLOW 400 can cause edema (swelling in legs or face) in up to 70% of users, managed by dose reduction or supportive measures. Gastrointestinal issues like nausea, vomiting, and diarrhea affect 40-50%, often resolving with antiemetics and dietary adjustments.​\n\nMusculoskeletal pain, cramps, and fatigue occur frequently, alongside rash and abdominal discomfort. Hematologic effects include neutropenia or thrombocytopenia, necessitating regular blood counts. Rare but serious risks involve liver enzyme elevation, heart failure, or hemorrhage; prompt reporting of symptoms like shortness of breath or yellowing skin is crucial.​\n\nAvoid grapefruit juice, as it elevates drug levels, and inform doctors of concurrent medications like CYP3A4 inhibitors. Pregnancy category D status advises contraception, with monitoring for growth retardation in exposed fetuses. Dizziness may impair driving, so caution is essential during initial weeks.​\n\nDosage and Administration Guidelines\nSwallow IMATIFLOW 400 whole with a meal and full glass of water to optimize pharmacokinetics and reduce esophageal irritation. The standard adult dose for CML chronic phase is 400mg daily; for accelerated phase or blast crisis, 600mg. GIST dosing mirrors 400mg, titrated based on tolerance and response.​\n\nRenal or hepatic impairment requires dose adjustments—reduce to 300-400mg in moderate cases. Do not crush or chew tablets. Missed doses should be taken promptly unless near the next, avoiding doubles. Long-term use demands quarterly monitoring of CBC, liver function, and ECG.​\n\nPrecautions and Interactions\nPatients with a cardiac history need baseline echocardiograms, as QT prolongation or effusion risks exist. Drug interactions abound: St. John's wort induces metabolism, reducing efficacy; ketoconazole boosts levels. Vaccines, especially live ones, are contraindicated during therapy.​\n\nRegular dermatologic checks mitigate skin cancer risk from prolonged use. Hydration combats fluid retention, and low-salt diets aid management. Steris Healthcare emphasizes patient education via counseling on adherence for optimal outcomes.​\n\nConclusion\nIMATIFLOW 400 (Imatinib IP 400mg) stands as a testament to targeted therapy's power, offering robust control over CML, GIST, and related cancers with a balance of efficacy and manageability. Its benefits in prolonging life and enhancing daily functioning far outweigh transient side effects for most when monitored diligently. Consult oncologists for personalized plans, ensuring this innovative treatment maximizes hope and health in the fight against cancer.", "price": 1827.0, "discountamount": 540.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2249, "imageuri": "https://productimages.withfloats.com/actual/6943b026ca1b0dcfc6c37820.png", "tileimageuri": "https://productimages.withfloats.com/tile/6943b026ca1b0dcfc6c37820.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-18T07:38:46.766Z", "updatedon": "2025-12-18T07:41:25.851Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/imatinib-ip-400mg/2249", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "IMATIFLOW 400", "category": "NEPHROLOGYRANGE", "tags": [ "Imatinib IP 400mg", "offering robust control over CML.", "related cancers with a balance of efficacy and manageability.", "innovative treatment maximizes hope and health in the fight against cancer.", "cancer therapy.", "fuel cancer cell growth.", "chemotherapy." ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "691f0bfb7357125af3e94c2b", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Sucralfate Tinidazole and Povidone Iodine Ointment", "description": "Sucralfate, Tinidazole, and Povidone Iodine Ointment is an advanced multi-action topical formulation designed to promote rapid wound healing, prevent infection, and enhance tissue regeneration. This combination therapy is widely used in dermatology, surgery, gynecology, and general wound management due to its broad-spectrum antimicrobial activity and strong healing-supportive characteristics. Each active ingredient plays a unique and complementary role, making this ointment highly effective in managing acute and chronic wounds, ulcers, burns, and infected skin lesions.\n\nAt the core of the formulation, Sucralfate acts as a protective barrier over damaged tissues. It binds to proteins at the wound site, forming a protective layer that shields the area from external irritants and bacterial contamination. This barrier not only promotes faster healing but also enhances tissue regeneration by stimulating growth factors and improving blood supply to the injured surface.\n\nTinidazole, a potent antiprotozoal and antibacterial agent, further strengthens the formulation by targeting anaerobic bacteria and protozoa commonly responsible for wound infections. Its inclusion helps reduce microbial load, prevent secondary infections, and create an ideal environment for clean and complication-free healing.\n\nFinally, Povidone Iodine, a trusted antiseptic, provides broad-spectrum germicidal action against bacteria, fungi, viruses, and spores. It effectively reduces wound contamination, minimizes odor, and prevents colonization of harmful microorganisms. Together, these ingredients create a synergistic effect that supports comprehensive wound management.\n\nProduct Uses\n\nThis ointment is commonly prescribed for:\n\nDiabetic foot ulcers\nHelps control infection while promoting tissue repair in complex ulcers.\n\nPressure sores and bedsores\nProvides protection and healing acceleration for chronic wounds.\n\nBurns (first and second degree)\nPrevents infection and reduces healing time.\n\nMinor cuts, abrasions, and skin injuries\nIdeal for daily wound care and minor trauma.\n\nPost-surgical wounds\nHelps prevent infection and supports clean healing.\n\nInfected wounds or skin lesions\nEffective against wounds contaminated with anaerobic bacteria or other pathogens.\n\nGynecological wound care\nMay be used for episiotomy care or infected perineal wounds under medical supervision.\n\nKey Benefits\n1. Broad-Spectrum Antimicrobial Protection\n\nThe combination of Tinidazole and Povidone Iodine provides robust defense against bacteria, fungi, protozoa, and viruses, significantly reducing infection risk.\n\n2. Accelerated Healing and Tissue Regeneration\n\nSucralfate forms a protective layer that maintains moisture balance, promotes granulation tissue formation, and speeds up recovery.\n\n3. Reduced Inflammation and Discomfort\n\nBy minimizing bacterial load and shielding damaged tissues, the ointment helps reduce redness, swelling, and pain.\n\n4. Ideal for Complex and Chronic Wounds\n\nEspecially effective for ulcers, burns, and infected wounds where multiple layers of treatment are needed.\n\n5. Odor Control in Infected Wounds\n\nPovidone Iodine’s antimicrobial action helps reduce foul odor associated with infected or necrotic tissue.\n\n6. Safe and Well-Tolerated\n\nWhen used as directed, this combination ointment is suitable for a wide range of patients, including those with difficult-to-heal wounds.\n\nPossible Side Effects\n\nWhile generally safe, some individuals may experience:\n\nMild skin irritation or redness\n\nBurning or stinging sensation at the application site\n\nDryness or peeling of skin\n\nAllergic reactions (rare), such as rash or itching\n\nTemporary discoloration of skin due to Povidone Iodine\n\nSensitivity reactions in iodine-allergic individuals\n\nPatients with thyroid disorders, severe burns, or extensive wounds should use Povidone Iodine-containing products only under medical guidance.\n\nConclusion\n\nSucralfate, Tinidazole, and Povidone Iodine Ointment stands out as a highly effective and versatile wound-care solution. Its triple-action design—protective, antimicrobial, and regenerative—makes it ideal for managing complicated wounds, preventing infection, and supporting faster, cleaner healing. Whether used for chronic ulcers, burns, surgical wounds, or everyday skin injuries, this formulation offers a reliable and scientifically supported approach to comprehensive wound management. With its blend of protection, infection control, and healing enhancement, it remains a valuable tool for both healthcare professionals and patients seeking superior wound-care outcomes.", "price": 98.0, "discountamount": 29.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2214, "imageuri": "https://productimages.withfloats.com/actual/691f0bfde83a250c0e084bb9.png", "tileimageuri": "https://productimages.withfloats.com/tile/691f0bfde83a250c0e084bb9.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-11-20T12:39:23.314Z", "updatedon": "2025-11-29T06:52:45.216Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/sucralfate-tinidazole-and-povidone-iodine-ointment/2214", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Steris Healthcare Pvt. Ltd", "category": "Gerneral", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6880ce12b566f87e592f9db9", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": " Etophylline, Theophylline and Salbutamol Tablets", "description": "SLO THEO ES Tablets is a powerful triple-action bronchodilator formulation designed to provide relief from respiratory conditions such as asthma, chronic bronchitis, chronic obstructive pulmonary disease (COPD), and other obstructive airway disorders. This unique blend of Etophylline, Theophylline, and Salbutamol works synergistically to relax the bronchial muscles, improve airflow, and reduce the severity and frequency of bronchospasms.\n\nBy combining etophylline and theophylline tablets with salbutamol, SLO THEO ES delivers a comprehensive respiratory support mechanism that not only opens up the airways but also helps in reducing inflammation and enhancing oxygen intake in the lungs. It is formulated to offer rapid relief while also supporting long-term control of respiratory symptoms.\n\nWhat is SLO THEO ES?\nSLO THEO ES is a combination medication containing etophylline 231 mg, theophylline 69 mg, and salbutamol 4 mg. Each of these components serves a specific function in easing breathing difficulties:\nEtophylline is a derivative of theophylline and acts as a bronchodilator with additional anti-inflammatory effects.\nTheophylline is a methylxanthine that relaxes the smooth muscles of the airways and improves diaphragm function.\nSalbutamol is a β2-adrenergic agonist that quickly relieves bronchospasm by relaxing airway muscles.\n\nThis combination makes SLO THEO ES highly effective for individuals who require both immediate and sustained bronchodilation.\nUses of SLO THEO ES Tablets:\nSLO THEO ES is prescribed for a range of chronic and acute respiratory conditions. It is especially beneficial in:\nBronchial asthma\nChronic Obstructive Pulmonary Disease (COPD)\nEmphysema\nChronic bronchitis\n\nAllergic bronchitis\n\nWheezing and breathlessness due to bronchospasm\n\nOther obstructive airway diseases\n\nThe etophylline and theophylline tablets in the formulation work on the central and peripheral pathways of the respiratory system, while salbutamol provides rapid symptom relief during acute attacks.\n\nSide Effects of SLO THEO ES Tablets:\nAs with most medications, SLO THEO ES may cause side effects, although not everyone experiences them. The most commonly reported side effects include:\n\nPalpitations\nNausea or vomiting\nRestlessness or anxiety\nTremors or shakiness\nInsomnia\nHeadache\nIncreased heart rate\n\nGastric discomfort\nSerious but rare side effects can include arrhythmias, severe hypotension, or seizures, especially if used in high doses or in sensitive individuals.\nPrecautions Before Using SLO THEO ES Tablets:\nBefore beginning treatment with SLO THEO ES, it is important to inform your doctor about your medical history, particularly if you have:\n\nHeart disease or high blood pressure\n\nHyperthyroidism\n\nPeptic ulcers\n\nSeizure disorders\n\nLiver or kidney impairment\n\nGlaucoma\n\nDiabetes mellitus\n\nPregnant or breastfeeding women should use SLO THEO ES only under medical supervision. Avoid alcohol or other stimulants that may enhance side effects. Do not exceed the prescribed dosage, and always follow the treatment duration recommended by your physician.\n\nDrug Interactions – What Drugs Interact with SLO THEO ES Tablets?\nSLO THEO ES may interact with several medications, altering their effectiveness or increasing the risk of adverse effects. Inform your healthcare provider if you are taking:\n\nBeta-blockers (e.g., propranolol)\n\nDiuretics (e.g., furosemide)\n\nOral contraceptives\n\nMacrolide antibiotics (e.g., erythromycin)\n\nAntiepileptic drugs (e.g., phenytoin, carbamazepine)\n\nFluoroquinolone antibiotics\n\nCimetidine (a gastric acid reducer)\n\nSteroids or other bronchodilators\n\nAlso, avoid consuming large quantities of caffeine, as both caffeine and theophylline belong to the same chemical class and can increase the risk of overstimulation.\n\nConclusion:\nSLO THEO ES Tablets offer an effective solution for managing obstructive respiratory conditions with its robust combination of etophylline, theophylline, and salbutamol. The synergistic action of these bronchodilators makes it an ideal choice for both acute symptom control and long-term respiratory support. However, due caution should be exercised regarding dosage, potential interactions, and side effects. Always consult your physician before starting or stopping this medication to ensure safe and effective use tailored to your condition.", "price": 95.0, "discountamount": 29.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2150, "imageuri": "https://productimages.withfloats.com/actual/6880ce15934b5c7d9f2ee4f8.png", "tileimageuri": "https://productimages.withfloats.com/tile/6880ce15934b5c7d9f2ee4f8.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-07-23T11:57:06.443Z", "updatedon": "2025-12-18T07:11:17.333Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/-etophylline-theophylline-and-salbutamol-tablets/2150", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Etophylline, Theophylline and Salbutamol Tablets", "category": "ASTHMARANGE", "tags": [ "Etophylline, Theophylline and Salbutamol Tablets", "chronic obstructive pulmonary disease", "relief from respiratory" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "66697a96b453b6167c504bca", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "DIOWELPREX ER 750 ", "description": "DIOWELPREX ER 750 \nDivalproex (75mg)\nIntroduction\nDIOWELPREX ER 750 contains Divalproex (750 mg) in an extended-release formulation, designed to provide effective management of seizures, bipolar disorder, and migraine prophylaxis. Divalproex is a well-established medication known for its efficacy in stabilizing mood, controlling seizures, and preventing migraines, making it a versatile treatment option for various neurological and psychiatric conditions.\n\nKey Ingredient and Its Benefits\nDivalproex (750 mg)\nSeizure Control: Divalproex is highly effective in managing different types of seizures, including absence seizures, complex partial seizures, and generalized seizures.\nMood Stabilization: It is commonly used to stabilize mood in patients with bipolar disorder, helping manage both manic and depressive episodes.\nMigraine Prophylaxis: Divalproex helps prevent migraine headaches, reducing their frequency and severity.\nExtended-Release Formulation: The extended-release formulation ensures a steady release of the medication over time, providing consistent therapeutic effects and reducing the need for multiple daily doses.\nBenefits of DIOWELPREX ER 750\nEffective Seizure Management: DIOWELPREX ER 750 provides robust control of various types of seizures, enhancing the quality of life for patients with epilepsy.\nMood Stabilization: It effectively stabilizes mood in patients with bipolar disorder, reducing the frequency and intensity of both manic and depressive episodes.\nMigraine Prevention: The medication helps prevent migraine headaches, significantly reducing their occurrence and severity.\nConvenient Dosage: The extended-release formulation offers the convenience of once-daily dosing, ensuring consistent medication levels and improving patient compliance.\nDosage and Administration\nDosage\nSeizure Control: The typical starting dosage for adults is 10-15 mg/kg/day, gradually increasing to the desired dose. The maintenance dose is typically 30-60 mg/kg/day, taken once or twice daily.\nBipolar Disorder: The usual starting dose is 750 mg/day, which may be increased as needed to achieve clinical efficacy, with a maximum dose of 60 mg/kg/day.\nMigraine Prophylaxis: The typical dose is 500-1000 mg/day, taken once or divided into two doses.\nAdministration\nOral Use: Swallow the tablet whole with a full glass of water. Do not crush, chew, or break the tablet, as it is designed to release the medication slowly over time.\nConsistency: For optimal results, take DIOWELPREX ER 750 at the same time each day to maintain consistent medication levels in your bloodstream.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW \nhttps://www.sterisonline.com/product/diowelprex-er-750-134194", "price": 215.0, "discountamount": 64.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "life", "need", "manic", "EMAIL", "water", "dosing", "750 mg", "adults", "tablet", "quality", "epilepsy", "patients", "Benefits", "30-60 mg", "Oral Use", "10-15 mg", "severity", "intensity", "migraines", "frequency", "two doses", "same time", "full glass", "occurrence", "Divalproex", "convenience", "500-1000 mg", "Consistency", "bloodstream", "information", "Introduction", "sterisonline", "maximum dose", "desired dose", "typical dose", "sterispharma", "CALL/WHATSAPP", "DIOWELPREX ER", "various types", "robust control", "steady release", "Key Ingredient", "optimal results", "Seizure Control", "different types", "absence seizures", "bipolar disorder", "maintenance dose", "Convenient Dosage", "clinical efficacy", "migraine headaches", "Mood Stabilization", "patient compliance", "Migraine Prevention", "depressive episodes", "usual starting dose", "generalized seizures", "multiple daily doses", "various neurological", "migraine prophylaxis", "effective management", "Administration Dosage", "psychiatric conditions", "typical starting dosage", "complex partial seizures", "versatile treatment option", "consistent medication levels", "extended-release formulation", "Effective Seizure Management", "consistent therapeutic effects" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1820, "imageuri": "https://productimages.withfloats.com/actual/66697a995e294343790be01a.png", "tileimageuri": "https://productimages.withfloats.com/tile/66697a995e294343790be01a.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-12T10:38:14.668Z", "updatedon": "2024-06-27T05:44:07.864Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/diowelprex-er-750-/1820", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "DIOWELPREX ER 750 ", "category": "NEUROLOGY RANGE", "tags": [ "divalproex (75mg) price", "divalproex (75mg) tablets", "divalproex 500 mg side effects", "divalproex sodium 500 mg" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "666979bfca84cd189c25b25b", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "DIOWELPREX ER 500 ", "description": "DIOWELPREX ER 500 \nDivalproex ER (500mg)\nIntroduction\nDIOWELPREX ER 500 contains Divalproex (500 mg) in an extended-release formulation, designed to provide effective management of seizures, bipolar disorder, and migraine prophylaxis. Divalproex is a well-established medication known for its ability to stabilize mood, control seizures, and prevent migraines, making it a versatile option for various neurological and psychiatric conditions.\n\nKey Ingredient and Its Benefits\nDivalproex (500 mg)\nSeizure Control: Divalproex is highly effective in managing different types of seizures, including absence seizures, complex partial seizures, and generalized seizures.\nMood Stabilization: It is commonly used to stabilize mood in patients with bipolar disorder, helping manage both manic and depressive episodes.\nMigraine Prophylaxis: Divalproex helps prevent migraine headaches, reducing their frequency and severity.\nExtended-Release Formulation: The extended-release formulation ensures a steady release of the medication over time, providing consistent therapeutic effects and reducing the need for multiple daily doses.\nBenefits of DIOWELPREX ER 500\nEffective Seizure Management: DIOWELPREX ER 500 provides robust control of various types of seizures, enhancing the quality of life for patients with epilepsy.\nMood Stabilization: It effectively stabilizes mood in patients with bipolar disorder, reducing the frequency and intensity of both manic and depressive episodes.\nMigraine Prevention: The medication helps prevent migraine headaches, significantly reducing their occurrence and severity.\nConvenient Dosage: The extended-release formulation offers the convenience of once-daily dosing, ensuring consistent medication levels and improving patient compliance.\nDosage and Administration\nDosage\nSeizure Control: The typical starting dosage for adults is 10-15 mg/kg/day, gradually increasing to the desired dose. The maintenance dose is typically 30-60 mg/kg/day, taken once or twice daily.\nBipolar Disorder: The usual starting dose is 750 mg/day, which may be increased as needed to achieve clinical efficacy, with a maximum dose of 60 mg/kg/day.\nMigraine Prophylaxis: The typical dose is 500-1000 mg/day, taken once or divided into two doses.\nAdministration\nOral Use: Swallow the tablet whole with a full glass of water. Do not crush, chew, or break the tablet, as it is designed to release the medication slowly over time.\nConsistency: For optimal results, take DIOWELPREX ER 500 at the same time each day to maintain consistent medication levels in your bloodstream.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW \nhttps://www.sterisonline.com/product/diowelprex-er-500-133557\n", "price": 199.0, "discountamount": 59.7, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "life", "need", "500mg", "EMAIL", "water", "manic", "adults", "750 mg", "tablet", "dosing", "500 mg", "quality", "ability", "Benefits", "severity", "30-60 mg", "10-15 mg", "epilepsy", "patients", "Oral Use", "same time", "migraines", "frequency", "two doses", "intensity", "full glass", "occurrence", "convenience", "500-1000 mg", "Consistency", "bloodstream", "information", "Introduction", "sterisonline", "sterispharma", "typical dose", "desired dose", "maximum dose", "CALL/WHATSAPP", "various types", "Divalproex ER", "DIOWELPREX ER", "robust control", "steady release", "Key Ingredient", "optimal results", "Seizure Control", "different types", "versatile option", "bipolar disorder", "maintenance dose", "absence seizures", "clinical efficacy", "Convenient Dosage", "migraine headaches", "Mood Stabilization", "patient compliance", "depressive episodes", "Migraine Prevention", "usual starting dose", "generalized seizures", "various neurological", "migraine prophylaxis", "effective management", "multiple daily doses", "Administration Dosage", "psychiatric conditions", "typical starting dosage", "complex partial seizures", "extended-release formulation", "Effective Seizure Management", "consistent medication levels", "consistent therapeutic effects" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1819, "imageuri": "https://productimages.withfloats.com/actual/666979c2f068be46bde8c652.png", "tileimageuri": "https://productimages.withfloats.com/tile/666979c2f068be46bde8c652.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-12T10:34:39.517Z", "updatedon": "2024-06-27T05:40:59.394Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/diowelprex-er-500-/1819", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "DIOWELPREX ER 500 ", "category": "NEUROLOGY RANGE", "tags": [ "divalproex 500 mg side effects", "depakote side effects sexually", "divalproex 500 mg price", "divalproex 500 mg uses", "divalproex sodium 500 mg" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "66697894162db0236048937c", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "DIOWELPREX ER 250 ", "description": "DIOWELPREX ER 250\nDivalproex ER (250mg) \nIntroduction\nDIOWELPREX ER 250 contains Divalproex (250 mg) in an extended-release formulation, designed to provide effective management of seizures, bipolar disorder, and migraine prophylaxis. Divalproex is a widely used medication known for its efficacy in stabilizing mood, controlling seizures, and preventing migraines, making it a versatile treatment option for various neurological and psychiatric conditions.\n\nKey Ingredient and Its Benefits\nDivalproex (250 mg)\nSeizure Control: Divalproex is effective in managing various types of seizures, including absence seizures, complex partial seizures, and multiple seizure types.\nMood Stabilization: It is commonly used to stabilize mood in patients with bipolar disorder, helping to manage manic and depressive episodes.\nMigraine Prophylaxis: Divalproex is also effective in preventing migraine headaches, reducing their frequency and severity.\nExtended-Release Formulation: The extended-release formulation ensures a steady release of the medication over time, providing consistent therapeutic effects and reducing the need for multiple daily doses.\nBenefits of DIOWELPREX ER 250\nEffective Seizure Management: DIOWELPREX ER 250 provides robust control of various types of seizures, improving quality of life for patients with epilepsy.\nMood Stabilization: It effectively stabilizes mood in patients with bipolar disorder, reducing the frequency and intensity of manic and depressive episodes.\nMigraine Prevention: The medication helps prevent migraine headaches, reducing their frequency and severity.\nConvenient Dosage: The extended-release formulation offers the convenience of once-daily dosing, ensuring consistent medication levels and improving patient compliance.\nDosage and Administration\nDosage\nSeizure Control: The typical starting dosage for adults is 10-15 mg/kg/day, gradually increasing to the desired dose. The maintenance dose is typically 30-60 mg/kg/day, divided into one or two doses.\nBipolar Disorder: The usual starting dose is 750 mg/day, increasing as needed to achieve clinical efficacy, with a maximum dose of 60 mg/kg/day.\nMigraine Prophylaxis: The typical dose is 500-1000 mg/day, divided into one or two doses.\nAdministration\nOral Use: Swallow the tablet whole with a full glass of water. Do not crush, chew, or break the tablet, as it is designed to release the medication slowly over time.\nConsistency: For optimal results, take DIOWELPREX ER 250 at the same time each day to maintain consistent medication levels in your bloodstream.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\nhttps://www.sterisonline.com/product/diowelprex-er-250-133556", "price": 149.0, "discountamount": 44.7, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "one", "life", "need", "manic", "EMAIL", "250mg", "water", "250 mg", "750 mg", "tablet", "dosing", "adults", "quality", "severity", "10-15 mg", "30-60 mg", "epilepsy", "Oral Use", "patients", "Benefits", "migraines", "intensity", "same time", "frequency", "two doses", "full glass", "bloodstream", "Consistency", "convenience", "500-1000 mg", "information", "Introduction", "sterisonline", "desired dose", "sterispharma", "typical dose", "maximum dose", "DIOWELPREX ER", "CALL/WHATSAPP", "Divalproex ER", "various types", "robust control", "steady release", "Key Ingredient", "optimal results", "Seizure Control", "bipolar disorder", "absence seizures", "maintenance dose", "Convenient Dosage", "clinical efficacy", "patient compliance", "migraine headaches", "Mood Stabilization", "depressive episodes", "usual starting dose", "Migraine Prevention", "effective management", "multiple daily doses", "various neurological", "migraine prophylaxis", "Administration Dosage", "multiple seizure types", "psychiatric conditions", "typical starting dosage", "complex partial seizures", "versatile treatment option", "extended-release formulation", "Effective Seizure Management", "consistent medication levels", "consistent therapeutic effects" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1818, "imageuri": "https://productimages.withfloats.com/actual/66697896c9162f54a15623e6.png", "tileimageuri": "https://productimages.withfloats.com/tile/66697896c9162f54a15623e6.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-12T10:29:40.204Z", "updatedon": "2024-06-27T05:39:46.08Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/diowelprex-er-250-/1818", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "DIOWELPREX ER 250 ", "category": "NEUROLOGY RANGE", "tags": [ "divalproex er 250 mg", "divalproex 250 mg side effects", "divalproex er 250 mg price", "divalproex 250 mg brand name", "divalproex extended-release 250 mg reviews" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "666977d78999680f14808f3a", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "CLOZAPINUM 50 ", "description": "CLOZAPINUM 50 \nClozapine (50mg)\nIntroduction\nCLOZAPINUM 50 contains Clozapine (50 mg), an atypical antipsychotic medication used to treat schizophrenia in patients who have not responded adequately to other treatments. Clozapine is highly effective in reducing the symptoms of schizophrenia, improving overall quality of life for patients with treatment-resistant schizophrenia.\n\nKey Ingredient and Its Benefits\nClozapine (50 mg)\nAntipsychotic Properties: Clozapine works by altering the actions of neurotransmitters in the brain, particularly dopamine and serotonin, which are thought to be involved in schizophrenia.\nEffective Symptom Control: It is highly effective in controlling both positive symptoms (hallucinations, delusions) and negative symptoms (social withdrawal, lack of motivation) of schizophrenia.\nReduction of Suicidal Behavior: Clozapine has been shown to reduce the risk of recurrent suicidal behavior in patients with schizophrenia or schizoaffective disorder.\nImproved Cognitive Function: It may help improve cognitive functions such as attention, memory, and executive function in patients with schizophrenia.\nBenefits of CLOZAPINUM 50\nEffective Treatment for Resistant Schizophrenia: CLOZAPINUM 50 provides robust relief for patients who have not responded to other antipsychotic treatments, improving overall symptoms and functioning.\nReduction in Positive and Negative Symptoms: It effectively controls both the positive and negative symptoms of schizophrenia, enhancing the patient’s quality of life.\nDecreased Suicidal Risk: Clozapine reduces the risk of recurrent suicidal behavior, providing additional protection for vulnerable patients.\nCognitive Enhancement: It may contribute to improvements in cognitive functions, aiding in better overall mental health management.\nDosage and Administration\nDosage\nSchizophrenia: The typical starting dosage for adults is 12.5 mg once or twice daily, gradually increased by 25-50 mg increments to a target dose of 300-450 mg per day. The maximum dose is 900 mg per day, based on the patient's response and tolerability. The exact dosage of CLOZAPINUM 50 should be determined by a healthcare provider.\nAdministration\nOral Use: Swallow the tablet whole with a full glass of water. It can be taken with or without food.\nConsistency: For optimal results, take CLOZAPINUM 50 at the same times each day to maintain consistent medication levels in your bloodstream.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW \nhttps://www.sterisonline.com/product/clozapinum-50-134382", "price": 58.1, "discountamount": 18.1, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "life", "food", "lack", "EMAIL", "water", "brain", "900 mg", "tablet", "memory", "adults", "product", "actions", "12.5 mg", "Benefits", "Oral Use", "dopamine", "response", "serotonin", "Clozapine", "attention", "Reduction", "delusions", "300-450 mg", "CLOZAPINUM", "full glass", "motivation", "same times", "information", "bloodstream", "Consistency", "target dose", "functioning", "improvements", "tolerability", "sterisonline", "exact dosage", "maximum dose", "Introduction", "sterispharma", "robust relief", "CALL/WHATSAPP", "hallucinations", "Key Ingredient", "optimal results", "overall quality", "other treatments", "overall symptoms", "positive symptoms", "neurotransmitters", "negative symptoms", "social withdrawal", "executive function", "25-50 mg increments", "Effective Treatment", "cognitive functions", "vulnerable patients", "healthcare provider", "Cognitive Enhancement", "additional protection", "Administration Dosage", "Decreased Suicidal Risk", "typical starting dosage", "Antipsychotic Properties", "schizoaffective disorder", "Effective Symptom Control", "Improved Cognitive Function", "recurrent suicidal behavior", "consistent medication levels", "other antipsychotic treatments", "overall mental health management", "treatment-resistant schizophrenia", "atypical antipsychotic medication" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1817, "imageuri": "https://productimages.withfloats.com/actual/667d234bba7e6420d2a51274.png", "tileimageuri": "https://productimages.withfloats.com/tile/667d234bba7e6420d2a51274.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-12T10:26:31.16Z", "updatedon": "2024-06-27T08:31:06.631Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/clozapinum-50-/1817", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "CLOZAPINUM 50 ", "category": "NEUROLOGY RANGE", "tags": [ "clozapine 50 mg uses", "clozapine side effects", "clozapine dosage", "clozapine side effects agranulocytosis", "clozapine 50 mg price" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }